Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 97-105 , March 2008

Hypertension prevention and control in Canada

  • Norman R.C. Campbell, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Norman R. C. Campbell, MD, Libin Cardiovascular Institute of Alberta, Health Sciences Centre, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1 Canada.

Received 23 July 2007 ,Accepted 4 October 2007.

References 

  1. World Health Organization. The World Health Report 2002. Geneva, Switzerland: World Health Organization; 2002;
  2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–2369
  3. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997;10:1097–1102
  4. Chockalingam A, Campbell N, Ruddy T, Taylor G, Déry V. High blood pressure prevention and control: a Canadian national strategy. CVD Prevention. 2000;3:81–93
  5. Campbell NRC. Canada Chair in hypertension prevention and control: a pilot project. Can J Cardiol. 2007;23:557–560
  6. Joffres MR, Hamet P, MacLean DR, L’Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001;14:1099–1105
  7. Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension (An evaluation of the literature). Hypertension. 2004;44:602–608
  8. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–1963
  9. McAlister FA, Campbell NRC, Zarnke K, Levine M, Graham ID. The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ. 2001;164:517–522
  10. Drouin D, Campbell NR, Kaczorowski J. Implementation of recommendations on hypertension: the Canadian Hypertension Education Program. Can J Cardiol. 2006;22:595–598
  11. McAlister FA. The Canadian Hypertension Education Program — a unique Canadian initiative. Can J Cardiol. 2006;22:559–564
  12. Campbell NR, Onysko J. The outcomes research task force and the Canadian Hypertension Education Program. Can J Cardiol. 2006;22:556–558
  13. Zarnke KB, Campbell NRC, McAlister FA, Levine M. A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol. 2000;16:1094–1102
  14. Campbell NRC, Nagpal S, Drouin D. Implementing hypertension recommendations. Can J Cardiol. 2001;17:851–856
  15. Campbell N, Drouin D, McAlister F, Onysko J, Tobe S, Touyz R. CHEP: a national program to improve the treatment and control of hypertension. Hypertension Canada. 2005;84:3–6
  16. Canadian Medical Association. Guidelines for Canadian Clinical Practice Guidelines. Ottawa, Canada: National Printers (Ottawa) Inc; 1994;
  17. The AGREE Collaboration. In: Appraisal of guidelines for research and evaluation. London, England: St. George’s Hospital Medical School; 2001;p. 1–24
  18. Campbell NRC, Burgess E, Choi BCK, Taylor G, Wilson E, Cléroux J, et al. Methods and an overview of the Canadian recommendations. CMAJ. 1999;160:S1–S6
  19. Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, et al. 1999 Canadian recommendations for the management of hypertension. CMAJ. 1999;161(suppl 12):S1–S17
  20. Onysko J, Maxwell C, Eliasziw M, Zhang J, Johansen H, Campbell N. Large increases in hypertension diagnosis and treatment in Canada following a healthcare professional education program. Hypertension. 2006;48:853–860
  21. Neutel CI, Campbell NRC. Antihypertensive medication use by recently diagnosed hypertensive Canadians. Can J Cardiol. 2007;23:561–565
  22. Campbell NRC, McAlister FA, Brant R, Levine M, Drouin D, Feldman R, et al. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens. 2003;21:1591–1597
  23. Campbell N, Brant R, Johansen H, Onysko J. Decreases in death from stroke, acute myocardial infarction and congestive heart failure in relationship to increases in total antihypertensive drug prescription in regions of Canada between 1998 and 2003. J Hypertens. 2006;24(suppl 6):S42
  24. Campbell NRC, Tu K, Brant R, Duong-Hua M, McAlister FA. The Impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension. 2006;47:22–28
  25. Tu K, Campbell NRC, Durong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension. 2005;45:1113–1118
  26. Reeves RA, Fodor JG, Gryfe CI, Patterson C, Spence JD. Report of the Canadian Hypertension Society Consensus Conference: 4 (Hypertension in the elderly). CMAJ. 1993;149:815–820
  27. Grabowsky T, Farquhar JW, Sunnarborg KR, Bales VS. Worldwide Efforts to Improve Heart Health: A Follow-up to the Catalonia Declaration — Selected Program Descriptions. U.S. Department of Health and Human Services; 1997;
  28. Petrella RJ, Campbell NRC. Awareness and misconception of hypertension in Canada: results of a national survey. Can J Cardiol. 2005;21:589–593
  29. Lenfant C. Reflections on hypertension control rates (A message from the director of the National Heart, Lung, and Blood Institute). Arch Intern Med. 2002;162:131–132
  30. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population (Data from the Health Examination Surveys, 1960 to 1991). Hypertension. 1995;26:60–69
  31. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population (Results from the Third National Health and Nutrition Examination Survey 1988–1991). Hypertension. 1995;25:305–313
  32. The North Karelia Project. Helsinki, Finland: the National Public Health Institute (KTL); 1995;
  33. Campbell NR, Petrella R, Kaczorowski J. Public education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in Canada. Can J Cardiol. 2006;22:599–603
  34. Blood Pressure Canada, Heart and Stroke Foundation of Canada, Canadian Hypertension Education Program (CHEP), Canadian Hypertension Society. 2007 Public Hypertension Recommendations. Canadian Nurse. 2007;103:special advertisement
  35. Ottawa Charter for Health Promotion. Can J Public Health. 1986;77:425–430
  36. Lalonde M. A New Perspective on the Health of Canadians, a Working Document. Ottawa, Canada: Department of National Health and Welfare; 1974;
  37. Scientific Advisory Committee on Nutrition. Salt and Health. Norwich, United Kingdom: The Stationery Office; 2003;
  38. Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation on Diet. Diet, Nutrition, and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation (Report No. 916). Geneva, Switzerland: World Health Organization; 2003;
  39. American Public Health Association. Reducing Sodium Content in the American Diet. American Public Health Association — Association News 2002 Policy Statements. 2002;5–6
  40. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308
  41. Council on Science and Public Health. Promotion of Healthy Lifestyles I: Reducing the Population Burden of Cardiovascular Disease by Reducing Sodium Intake (Report No. 10, A–06). American Medical Association; 2006;
  42. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Panel on Dietary Reference Intakes for Electrolytes and Water, Dietary Reference Intakes for Water, Potassium, Sodium, Chloride and Sulfate. Washington, D.C: National Academies Press; 2004;
  43. Garriguet D. Sodium consumption at all ages. Health Rep. 2007;18:47–52
  44. World Health Organization Nutrition and Food Security Programme. Food Based Dietary Guidelines in the WHO European Region. Copenhagen, Denmark: World Health Organization; 2003;
  45. Nissinen A, Kastarinen M, Tuomilehto J. Community control of hypertension — experiences from Finland. J Hum Hypertens. 2004;18:553–556
  46. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49:59–75
  47. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;357:848–851
  48. Tian H-G, Guo Z-Y, Hu G, Yu S-J, Sun W, Pietinen P, et al. Changes in sodium intake and blood pressure in a community-based intervention project in China. J Hum Hypertens. 1995;9:959–968
  49. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 1993;153:598–615
  50. Forte JG, Pereira Miguel JM, Pereira Miguel MJ, de Padua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989;3:179–184
  51. Sasaki N. The Salt Factor in Apoplexy and hypertension: epidemiological studies in Japan. In:  Yamori Y,  Lovenberg W,  Freis ED editor. Prophylactic Approach to Hypertensive Diseases. New York, New York: Raven Press; 1979;p. 46774
  52. Joffres M, Campbell NRC, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related healthcare costs in Canada. Can J Cardiol. 2007;23:437–443
  53. Campbell NRC, Onysko J, Johansen H, Gao R-N. Changes in cardiovascular deaths and hospitalization in Canada. Can J Cardiol. 2006;22:425–427

 Dr. Norman Campbell acknowledges the Canadian Institutes of Health Research for their support of the Canada Chair in Hypertension Prevention and Control. Dr. Campbell has provided talks for and sits on Advisory Boards of most pharmaceutical companies that produce antihypertensive drugs in Canada.

PII: S1933-1711(07)00203-3

doi: 10.1016/j.jash.2007.10.001

Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 97-105 , March 2008

Article Tools

* Image Usage & Resolution